Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72. doi: 10.1093/annonc/mdt354.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capecitabine
  • Carcinoembryonic Antigen / blood
  • Chemotherapy, Adjuvant
  • Chromosome Deletion
  • Chromosome Disorders / genetics
  • Chromosomes, Human, Pair 18 / genetics
  • Colonic Neoplasms / diagnosis*
  • Colonic Neoplasms / epidemiology
  • Colonic Neoplasms / therapy*
  • Colonoscopy
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Early Detection of Cancer*
  • Europe / epidemiology
  • Female
  • Fluorouracil / analogs & derivatives
  • Fluorouracil / therapeutic use
  • Follow-Up Studies
  • Humans
  • Intestinal Mucosa / pathology
  • Leucovorin / therapeutic use
  • Lymphatic Metastasis
  • Male
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm Staging
  • Occult Blood
  • Organoplatinum Compounds / therapeutic use
  • Oxaloacetates
  • Risk
  • Risk Assessment
  • Risk Factors
  • Sigmoidoscopy
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Carcinoembryonic Antigen
  • Organoplatinum Compounds
  • Oxaloacetates
  • Deoxycytidine
  • Capecitabine
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Chromosome 18 deletion syndrome
  • Folfox protocol
  • XELOX